Israeli companies listed on US stock exchanges
PolyPid Ltd. (PYPD)
Sector: Medical
Industry: Medical - Drugs
Exchange: Nasdaq
18 Hasivim Street, P.O Box 7126 Petach Tikva, Israel 4917002
IR Contact info
Name: Ori Warshavsky
Title: Chief Operating Officer - US Operations
Email: ori.w@polypid.com
Tel: +1.267.640.7592
PYPD on Major Financial Platforms:
Polypid is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
The Executives
Video Presentations
PP Presentation
